Jacobs Levy Equity Management’s IDEAYA Biosciences IDYA Stock Holding History

Jacobs Levy Equity Management’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-9,486	Closed	-$223K	–	1009
2023 Q2	$223K	Sell	9,486 -12,946	-58%	-$266K	﹤0.01%	919
2023 Q1	$308K	Buy	+22,432	New	+$374K	﹤0.01%	857
2020 Q4	–	Sell	-41,273	Closed	-$518K	–	1049
2020 Q3	$518K	Sell	41,273 -15,644	-27%	-$194K	0.01%	786
2020 Q2	$809K	Buy	56,917 +39,606	+229%	+$312K	0.01%	713
2020 Q1	$71K	Sell	17,311 -2,807	-14%	-$19.9K	﹤0.01%	968
2019 Q4	$151K	Buy	+20,118	New	+$144K	﹤0.01%	959

Other funds holding IDYA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CPX

Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Jacobs Levy Equity Management's IDYA Position: Q3 2023 in Review

Jacobs Levy Equity Management sold out of IDEAYA Biosciences (IDYA) in Q3 2023, closing a stake of 9,486 shares — an estimated $223K sold.

Jacobs Levy Equity Management first reported a position in IDYA in Q4 2019 and held it in 6 quarters. The position peaked at $809K in Q2 2020. 144 funds tracked by Wall St. Rank hold IDYA as of Q3 2023.

Jacobs Levy Equity Management reported no remaining IDEAYA Biosciences position as of Q3 2023 after selling out during the quarter.
Jacobs Levy Equity Management sold 9,486 IDEAYA Biosciences shares in Q3 2023, an estimated $223K.
Jacobs Levy Equity Management first reported a position in IDEAYA Biosciences in Q4 2019 and held it in 6 quarters.
Jacobs Levy Equity Management's IDEAYA Biosciences position peaked at $809K in Q2 2020.
144 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.